Community-Acquired Pneumonia in Adults Outpatient Management Algorithm oily Ta quinolone | Azthromycin PLUS EITHER [>| _ high dose amoxiciin 1 td ‘OR high dose amoxiclav 2g bid 10 Previously healthy ‘Recent antimicrobial patents without therapy (last months)? comorbidities A. 13 L__,| Levees wit nore onl 2 ‘uinolr ‘Aaithromycin OR dloxyeyeine om ‘Aathromycin PLUS EITHER high-dose amoxcilin 1 gta i OR high-dose amonclav2 9 bid 4 ‘OR cefuroxime OR cefpodoxime ae ee Recent antimicrobial YS OR esprea >| therapy ast 3 months)? fale, malignancies | ° 16 Outpatient Management i Levtioxacin + Treatment based on wer patent characteristics 7 auinoe + Pationt education ‘Azithromycin OR + Folow-up Levofloxacin A 18 © [>] Aspiration suspected | +] _Amoxélav OR clindamycin A 20 ry ‘aithromycin PLUS |] Nursing home patient. |}-———+| ‘amoxielay Levofloxacin A 2 B Lm) Recentinfuenza, |__| op high-dose amowlelav2 bid peetbie supa OR cefuroxime OR cefpodoxime| A (OR cefproai ‘Source: Community-acquired pneumonia in adults. Bloomington (MN) Institute for Clinical Systems Improvement (ICSI); 2008 May. 35 p,